Radient Amends Loan Facility as Part of Restructuring Plan
Radient Amends Loan Facility as Part of Restructuring Plan
Edmonton, Alberta--(Newsfile Corp. - April 4, 2022) - Radient Technologies Inc. (TSXV: RTI) ("Radient" or the "Company"), a commercial manufacturer of diverse, novel, and high-quality cannabis extracts and packaged products, announces the Company has amended the terms of an existing $8.5 million secured loan facility with Moskowitz Capital Mortgage Fund II Inc., an arm's length party ("Moskowitz").
艾伯塔省埃德蒙頓-(Newsfile Corp.-2022年4月4日)-Radient Technologies Inc. (TSXV：RTI)(“Radient”或“公司”)是一家生產多種、新穎和高質量大麻提取物和包裝產品的商業製造商，該公司宣佈，公司已經修改了與莫斯科維茨資本抵押基金II公司(Moskowitz Capital Mortgage Fund II Inc.)現有的850萬美元擔保貸款安排的條款。
The interest rate has been reduced to the greater of 9.99% or the Bank of Nova Scotia prime rate plus 7.54% per annum, revised downward from the greater of 15% or the Bank of Nova Scotia prime rate plus 12.55% per annum. The maturity date has been extended by one year to November 1, 2022 and the principal amount has been increased to approximately $9.93 million. The loan facility continues to be secured by a first priority mortgage on the land and buildings located at 4035, 4029, and 4025 101 St. N.W., Edmonton, Alberta.
利率已從15釐或豐業銀行最優惠利率加12.55釐下調至9.99釐或豐業銀行最優惠利率加7.54釐兩者中較大者。到期日延長一年至2022年11月1日，本金金額增加至約993萬美元。貸款安排繼續由位於艾伯塔省埃德蒙頓4035,4029和4025 101 St.N.W.的土地和建築的優先抵押擔保。
In connection with the amendment, Radient has agreed to pay Moskowitz $99,929 as a renewal fee in three equal installments and to issue a loan bonus to Moskowitz of 10 million non-transferable common share purchase warrants, each entitling Moskowitz to purchase one common share of Radient at an exercise price of $0.085 for one year following the date of issuance. No finder's fees are payable in connection with the amendment. All securities issued in connection with the amendment will be subject to a statutory hold period expiring four months and one day following the issuance date of the warrants. The issuance of the warrants is subject to the approval of the TSX Venture Exchange.
關於這項修訂，Radient已同意分三次等額向Moskowitz支付99,929美元作為續期費，並向Moskowitz發放1,000萬股不可轉讓普通股認購權證的貸款紅利，每份認股權證使Moskowitz有權以0.085美元的行使價購買Radient的一股普通股，發行日起一年內。不需要支付與修正案相關的發現者費用。所有與修訂相關而發行的證券將受法定持有期的規限，持有期由權證發行日期起計四個月零一天屆滿。認股權證的發行有待多倫多證券交易所創業板交易所的批准。
About Radient
Radient is a commercial manufacturer of diverse, novel, and high-quality cannabis extracts and packaged products. Radient develops specialty products and ingredients that contain a broad range of cannabinoid and terpene profiles while meeting the highest standards of quality and safety. Radient is focused on innovation with expertise in formulations and technologies offering unique solutions in the cannabis and wellness space. RadientInc.com
關於漸變
Radient是一家商業製造商，生產多種、新穎和高質量的大麻提取物和包裝產品。Radient開發的特種產品和成分含有廣泛的大麻素和萜類物質，同時滿足最高的質量和安全標準。Radient專注於創新，擁有配方和技術方面的專業知識，在大麻和健康領域提供獨特的解決方案。RadientInc.com
Contact Information:
Harry Kaura, CEO & Director
ir@radientinc.com
Ph: 780 465 1318
聯繫方式：
董事首席執行官哈里·考拉
郵箱：ir@Radientinc.com
電話：780 465 1318
NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
多倫多證券交易所創業板交易所及其監管服務提供商(該術語在多倫多證券交易所創業板交易所的政策中定義)均不對本新聞稿的充分性或準確性承擔責任。
To view the source version of this press release, please visit
要查看本新聞稿的源版本，請訪問